Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.
McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall H, Estcourt MJ, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Faust SN, Wadia U, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond P. McLeod C, et al. Among authors: estcourt mj. J Infect. 2024 Sep 26;89(6):106286. doi: 10.1016/j.jinf.2024.106286. Online ahead of print. J Infect. 2024. PMID: 39341401 Free article.
Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort Study.
Pérez Chacón G, Fathima P, Jones M, Estcourt MJ, Gidding HF, Moore HC, Richmond PC, Snelling T. Pérez Chacón G, et al. Among authors: estcourt mj. J Allergy Clin Immunol Pract. 2024 Mar;12(3):670-680. doi: 10.1016/j.jaip.2023.12.048. Epub 2024 Jan 4. J Allergy Clin Immunol Pract. 2024. PMID: 38182097
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.
McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall HS, Estcourt MJ, Wadia U, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Cain N, Brizuela R, Faust SN, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond PC. McLeod C, et al. Among authors: estcourt mj. J Infect. 2024 Nov 14:106346. doi: 10.1016/j.jinf.2024.106346. Online ahead of print. J Infect. 2024. PMID: 39550007 Free article.
Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial.
Pérez Chacón G, Estcourt MJ, Totterdell J, Marsh JA, Perrett KP, Campbell DE, Wood N, Gold M, Waddington CS, O' Sullivan M, McAlister S, Curtis N, Jones M, McIntyre PB, Holt PG, Richmond PC, Snelling T. Pérez Chacón G, et al. Among authors: estcourt mj. PLoS Med. 2024 Jun 10;21(6):e1004414. doi: 10.1371/journal.pmed.1004414. eCollection 2024 Jun. PLoS Med. 2024. PMID: 38857311 Free PMC article. Clinical Trial.
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO).
McLeod C, Ramsay J, Flanagan KL, Plebanski M, Marshall H, Dymock M, Marsh J, Estcourt MJ, Wadia U, Williams PCM, Tjiam MC, Blyth C, Subbarao K, Nicholson S, Faust S, Thornton RB, Mckenzie A, Snelling TL, Richmond P. McLeod C, et al. Among authors: estcourt mj. Trials. 2023 Mar 18;24(1):202. doi: 10.1186/s13063-023-07225-z. Trials. 2023. PMID: 36934272 Free PMC article.
Childhood vaccination and allergy: A systematic review and meta-analysis.
Navaratna S, Estcourt MJ, Burgess J, Waidyatillake N, Enoh E, Lowe AJ, Peters R, Koplin J, Dhamage SC, Lodge CJ. Navaratna S, et al. Among authors: estcourt mj. Allergy. 2021 Jul;76(7):2135-2152. doi: 10.1111/all.14771. Epub 2021 Mar 20. Allergy. 2021. PMID: 33569761
24 results